The New 2011 International Association for the Study of Lung Cancer/american Thoracic Society/european Respiratory Society Classification of Lung Adenocarcinoma in Resected Specimens: Clinicopathologic Relevance and Emerging Issues

Overview

Journal Korean J Pathol

Specialty Pathology

Date 2013 Sep 7

PMID 24009626

Citations 9

Authors

Seung Yeon Ha

Mee Sook Roh

Affiliations

Soon will be listed here.

Abstract

Pathologists play an increasingly important role in personalized medicine for patients with lung cancer as a result of the newly recognized relationship between histologic classification and molecular change. In 2011, the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) proposed a new architectural classification for invasive lung adenocarcinomas to provide uniform terminology and diagnostic criteria. This review highlighted the evolution of the classification of lung adenocarcinomas in resected specimens with special respect to both histologic subtyping and invasion. Histologic subtyping of lung adenocarcinoma has been updated based on five major predominant patterns. New concepts of adenocarcinoma in situ and minimally invasive adenocarcinomas have been introduced to define the condition of patients who are expected to have excellent survival. Although the new IASLC/ATS/ERS classification has promising clinical relevance, significant clarification remains necessary for the definitions of subtyping and invasion. More precise definitions and subsequent better education on the interpretation of terminology will be helpful for future studies.

Citing Articles

Radiomics for Classifying Histological Subtypes of Lung Cancer Based on Multiphasic Contrast-Enhanced Computed Tomography.

E L, Lu L, Li L, Yang H, Schwartz L, Zhao B J Comput Assist Tomogr. 2019; 43(2):300-306.

PMID: 30664116 PMC: 6527094. DOI: 10.1097/RCT.0000000000000836.

Tumor heterogeneity assessed by texture analysis on contrast-enhanced CT in lung adenocarcinoma: association with pathologic grade.

Liu Y, Liu S, Qu F, Li Q, Cheng R, Ye Z Oncotarget. 2017; 8(32):53664-53674.

PMID: 28881840 PMC: 5581139. DOI: 10.18632/oncotarget.15399.

Characterization of a transgenic mouse model exhibiting spontaneous lung adenocarcinomas with a metastatic phenotype.

Chang H, Lin Z, Wu M, Wang L, Chow Y, Jiang S PLoS One. 2017; 12(4):e0175586.

PMID: 28419107 PMC: 5395147. DOI: 10.1371/journal.pone.0175586.

Myoferlin expression in non-small cell lung cancer: Prognostic role and correlation with VEGFR-2 expression.

Song D, Ko G, Lee J, Lee J, Lee G, Kim H Oncol Lett. 2016; 11(2):998-1006.

PMID: 26893682 PMC: 4734036. DOI: 10.3892/ol.2015.3988.

Clinicopathological and prognostic significance of metastasis-associated protein 1 expression and its correlation with angiogenesis in lung invasive adenocarcinomas, based on the 2011 IASLC/ATS/ERS classification.

Li S, Tian H, Yue W, Li L, Gao C, Si L Oncol Lett. 2016; 11(1):224-230.

PMID: 26870192 PMC: 4727071. DOI: 10.3892/ol.2015.3839.

References

Borczuk A, Qian F, Kazeros A, Eleazar J, Assaad A, Sonett J . Invasive size is an independent predictor of survival in pulmonary adenocarcinoma. Am J Surg Pathol. 2008; 33(3):462-9. PMC: 2987634. DOI: 10.1097/PAS.0b013e318190157c. View

Travis W, Brambilla E, Noguchi M, Nicholson A, Geisinger K, Yatabe Y . Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med. 2012; 137(5):685-705. DOI: 10.5858/arpa.2012-0264-RA. View

Xu L, Tavora F, Burke A . 'Bronchioloalveolar carcinoma': is the term really dead? A critical review of a new classification system for pulmonary adenocarcinomas. Pathology. 2012; 44(6):497-505. DOI: 10.1097/PAT.0b013e3283579fda. View

Anami Y, Iijima T, Suzuki K, Yokota J, Minami Y, Kobayashi H . Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis. J Thorac Oncol. 2009; 4(8):951-8. DOI: 10.1097/JTO.0b013e3181ad8631. View

Paik J, Choi C, Kim H, Jang S, Choe G, Kim D . Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma. Lung Cancer. 2011; 76(3):403-9. DOI: 10.1016/j.lungcan.2011.11.008. View

Warth A, Muley T, Meister M, Stenzinger A, Thomas M, Schirmacher P . The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol. 2012; 30(13):1438-46. DOI: 10.1200/JCO.2011.37.2185. View

Travis W, Brambilla E, Noguchi M, Nicholson A, Geisinger K, Yatabe Y . International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011; 6(2):244-85. PMC: 4513953. DOI: 10.1097/JTO.0b013e318206a221. View

Nakazato Y, Maeshima A, Ishikawa Y, Yatabe Y, Fukuoka J, Yokose T . Interobserver agreement in the nuclear grading of primary pulmonary adenocarcinoma. J Thorac Oncol. 2013; 8(6):736-43. DOI: 10.1097/JTO.0b013e318288dbd8. View

De Oliveira Duarte Achcar R, Nikiforova M, Yousem S . Micropapillary lung adenocarcinoma: EGFR, K-ras, and BRAF mutational profile. Am J Clin Pathol. 2009; 131(5):694-700. DOI: 10.1309/AJCPBS85VJEOBPDO. View

10.

Yim J, Zhu L, Chiriboga L, Watson H, Goldberg J, Moreira A . Histologic features are important prognostic indicators in early stages lung adenocarcinomas. Mod Pathol. 2006; 20(2):233-41. DOI: 10.1038/modpathol.3800734. View

11.

Woo T, Okudela K, Mitsui H, Tajiri M, Yamamoto T, Rino Y . Prognostic value of the IASLC/ATS/ERS classification of lung adenocarcinoma in stage I disease of Japanese cases. Pathol Int. 2012; 62(12):785-91. DOI: 10.1111/pin.12016. View

12.

Warth A, Cortis J, Fink L, Fisseler-Eckhoff A, Geddert H, Hager T . Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification. Virchows Arch. 2012; 461(2):185-93. DOI: 10.1007/s00428-012-1263-6. View

13.

Yoshizawa A, Sumiyoshi S, Sonobe M, Kobayashi M, Fujimoto M, Kawakami F . Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. J Thorac Oncol. 2012; 8(1):52-61. DOI: 10.1097/JTO.0b013e3182769aa8. View

14.

Yoshida A, Tsuta K, Watanabe S, Sekine I, Fukayama M, Tsuda H . Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component. Lung Cancer. 2010; 72(3):309-15. DOI: 10.1016/j.lungcan.2010.09.013. View

15.

Miyoshi T, Satoh Y, Okumura S, Nakagawa K, Shirakusa T, Tsuchiya E . Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol. 2002; 27(1):101-9. DOI: 10.1097/00000478-200301000-00011. View

16.

Ahn S, Hwangbo W, Kim H, Kim C . Naked cuticle Drosophila 1 expression in histologic subtypes of small adenocarcinoma of the lung. Korean J Pathol. 2013; 47(3):211-8. PMC: 3701816. DOI: 10.4132/KoreanJPathol.2013.47.3.211. View

17.

Russell P, Wainer Z, Wright G, Daniels M, Conron M, Williams R . Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung.... J Thorac Oncol. 2011; 6(9):1496-504. DOI: 10.1097/JTO.0b013e318221f701. View

18.

Sica G, Yoshizawa A, Sima C, Azzoli C, Downey R, Rusch V . A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol. 2010; 34(8):1155-62. DOI: 10.1097/PAS.0b013e3181e4ee32. View

19.

Travis W, Brambilla E, Riely G . New pathologic classification of lung cancer: relevance for clinical practice and clinical trials. J Clin Oncol. 2013; 31(8):992-1001. DOI: 10.1200/JCO.2012.46.9270. View

20.

Sakurai H, Maeshima A, Watanabe S, Suzuki K, Tsuchiya R, Maeshima A . Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol. 2004; 28(2):198-206. DOI: 10.1097/00000478-200402000-00007. View